Incoming UW–Madison chancellor Jennifer Mnookin looks to build upon and advance the principles of the Wisconsin Idea in her new role. ...
Clinical Trials Arena demystifies how AI can potentially help participants stick to the study all the way to the end, while also pointing to clinical trial sponsor blind spots....
When people consider vaccines, many think about the pandemic and about preventing illness. However, certain UW researchers have a very different focus when they work with vaccines....
New global analysis has found that since 2014 the number of women younger than 60 years of age participating in breast cancer clinical trials has increased dramatically....
Jorge Osorio, an expert in epidemiology, virology and vaccines, has been named the next director of the University of Wisconsin–Madison’s Global Health Institute....
Moderna announced Thursday morning that it's asking the FDA to approve its COVID vaccine for kids under 6 years old. If authorized for emergency use, it would become the first eligible vaccine for kids younger than 5....
Artificial Intelligence (AI) has the power to ensure clinical trials are unbiased from the outset and draw better inferences about the different responses between men and women from clinical trials....
In honor of “Medical Laboratory Professionals Week” (April 24-30), we at the University of Wisconsin–Madison Clinical Research Office would like to express our gratitude to all of the lab professionals in our clinical research community!...
Early clinical trials suggest vaccines that activate T cells work better and faster and may protect people with weakened immune systems....
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move pharmaceutical therapies from the lab into the clinic....
